1990
Psychiatry, American Board of Psychiatry & Neurology.
1997
Addiction Psychiatry, Subspecialty Certification.
2005
Forensic Psychiatry, Subspecialty Certification.
1993 – 1995
Psy.D. (Doctor of Clinical Psychology), 1995: Institute for
Contemporary Psychoanalysis, LA, CA.
1988 – 1993
Candidate: Los Angeles Psychoanalytic Institute.
1988 – 1989
Fellow: University of Southern California Medical Center Anxiety
Disorders & Behavior Therapy Clinic.
1985 – 1988
Resident: UCLA Neuropsychiatric Institute.
1980 – 1984
M.D., 1984: University of California, Irvine.
1975 – 1980
B.A. with High Honors, Pharmacology, 1980: UCSB.
1977 – 1977
Institute for Shipboard Education, Semester at Sea Program;
Intensive cross-cultural immersion.
2004
Clinical Professor: UCLA.
1989-2003
Assistant/Associate Clinical Professor: UCLA.
2003
Distinguished Fellow: American Psychiatric Association.
1993-1996
Founding Director: UCLA Social & Performance Anxiety Clinic.
1992-1996
Associate Director of the UCLA Anxiety Disorders Clinic.
2001
President: Southern California Psychiatry Society.
2010
Reviewer: The American Journal of Psychiatry
2000
Advisory Board Member: International Paruresis Association
2001
Selectee: Best Doctors of America, Anxiety Disorders Category, Best Doctors, Inc.
2002
Selectee: Anxiety Disorders Category, Guide to America’s Top Psychiatrists; Consumers Research Council of America
2001
Selectee: Super Doctors; Superdoctors.com
2002
Biographee: Marquis Who’s Who in America, 55th Edition
2010-2015
Editor: Newsletter of the Psychiatric Clinical Faculty Assn, UCLA
2007-2015
Board of Directors: Psychiatric Clinical Faculty Assn, UCLA.
1996
Faculty: Institute for Contemporary Psychoanalysis.
2013
Member: New Center for Psychoanalysis.
2018
Member: St John’s Hospital Alumni Association
1997 – 1999
Process Group Leader: UCLA Neuropsychiatric Institute Residency
1992 – 1995
Chairman: Santa Monica Rotary Polio Eradication Committee
1993 – 1997
Board of Directors: NCCJ (A Human Relations Organization)
1989
Member: Anxiety and Depression Association of America and
Obsessive Compulsive Disorder Foundation
1983
Flying Samaritans Member: a group of doctors and pilots who fly to isolated rural areas of Mexico to provide medical treatment.
2003
Principal Investigator: Levetiracetam (N-type calcium channel
blocker) in the treatment of social phobia: UCB Pharma grant.
2000
Co-Investigator: Fluoxetine and Olanzapine in the treatment of
treatment-resistant depression: Lilly grant.
2000
Co-Investigator: Sigma opioid receptor agonist in the treatment of
depression: Otsuka grant.
1998
Principal Investigator: Substance P Antagonist in the
treatment of social phobia: Novartis grant.
1997
Co-Investigator: Lamotrigine in the treatment of bipolar
depression: Glaxo Wellcome grant.
1993
Principal Investigator: Brofaromine (Reversible MAO B Inhibitor)
in the treatment of social phobia. Ciba-Geigy grant.
1980
Lab Technician: Prepared and operated guinea pig atrium and
ileum live-tissue assays to screen compounds isolated from marine
organisms for potential pharmacologic activity.
Sea Grant Project.